European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

A ground-breaking biomolecular production platform for safer, more efficient and sustainable pest control and crop health management

Descrizione del progetto

Prodotti rivoluzionari per la salvaguardia delle colture

La dipendenza dai fertilizzanti chimici in agricoltura sta mettendo a dura prova l’ambiente, mettendo in evidenza la necessità di alternative quali i biopesticidi. La loro preferenza sui pesticidi ha portato a un aumento della domanda di molecole di origine biologica. La start-up francese LIPOFABRIK ha sviluppato e brevettato una metodologia di produzione per la micosubtilina, un lipopeptide naturale prodotto da Bacillus subtilis con comprovati effetti antimicotici e stimolanti su diverse colture. Ha inoltre sviluppato un altro prodotto che mostra attività biostimolante. Il progetto Lipofabrik, finanziato dall’UE, si propone di superare l’attuale carenza di mercato di questo tipo di biomolecola. A tal fine, industrializzerà il processo di formulazione e produzione, consentendo una produzione di massa a prezzi competitivi.

Obiettivo

LIPOFABRIK is an innovative start-up from the University of Lille, specialized in the production of biological molecules with application in the phytosanitary, food, cosmetic and medical cleaning markets. Our specialised team of researchers has developed and patented a production methodology for mycosubtilin, a bioactive lipopeptide produced by Bacillus subtilis with demonstrated antifungal and stimulating effects in several crops. Since 2013, LIPOFABRIK holds exclusivity on this patent, focused now on its market exploitation and IP portfolio expansion.
LIPOFABRIK has invested over 5 years and €2.18 million in the development, validation and business preparation of mycosubtilin for application as biopesticide and biostimulant. We have demonstrated the safety, efficiency and effectiveness of mycosubtilin against fungal infections in open field and greenhouses, reporting the superior efficacy in several peer review publications.
We have a lipopeptide production plant in pilot stage, yielding 50 kg per year. In views of the ongoing market demand, regulatory requirements and unmet needs faced by manufacturers of plant protection products, we aim to industrialise our production line responding to the market demand at a cost-efficient price. LIPOFABRIK aims to produce at quantities 10 times higher, with prices 5 times lower and higher purity than competitors offer.
This project aims to overcome the current market shortage on lipopeptides, industrialising our proprietary formulation and process to be aligned with the voiced demand. Upon completion, we will operate the first industrial lipopeptide production plant in Europe, providing a sustainable and cost-efficient solution for natural plant protection. Our proprietary biopesticide ingredients will be sold at a competitive price, being the only European company with capability to deliver bulk amounts, from 200-400 tons per year, of lipopeptides needed for large scale application in agriculture and gardening.

Invito a presentare proposte

H2020-EIC-SMEInst-2018-2020

Vedi altri progetti per questo bando

Bando secondario

H2020-SMEInst-2018-2020-2

Meccanismo di finanziamento

SME-2 - SME instrument phase 2

Coordinatore

LIPOFABRIK
Contribution nette de l'UE
€ 1 586 345,25
Indirizzo
UNIVERSITE LILLE 1 POLYTECH LILLE AVENUE PAUL LANGEVIN
59655 VILLENEUVE D'ASCQ
Francia

Mostra sulla mappa

PMI

L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.

Regione
Hauts-de-France Nord-Pas de Calais Nord
Tipo di attività
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Collegamenti
Costo totale
€ 2 266 207,50